Factors underlying COVID-19 booster vaccine uptake among adults in Belgium

por Vermeiren, Elias, van Loenhout, Joris A. F., Nasiadka, Léonore, Stouten, Veerle, Billuart, Matthieu, Van Evercooren, Izaak, Catteau, Lucy, Hubin, Pierre
Publicado 2023

Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium

por Stouten, Veerle, Hubin, Pierre, Haarhuis, Freek, van Loenhout, Joris A. F., Billuart, Matthieu, Brondeel, Ruben, Braeye, Toon, Van Oyen, Herman, Wyndham-Thomas, Chloé, Catteau, Lucy
Publicado 2022

COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022

por Braeye, Toon, van Loenhout, Joris A F, Brondeel, Ruben, Stouten, Veerle, Hubin, Pierre, Billuart, Matthieu, Chung, Pui Yan Jenny, Vandromme, Mathil, Wyndham-Thomas, Chloé, Blot, Koen, Catteau, Lucy
Publicado 2023

Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022

por Braeye, Toon, Catteau, Lucy, Brondeel, Ruben, van Loenhout, Joris A.F., Proesmans, Kristiaan, Cornelissen, Laura, Van Oyen, Herman, Stouten, Veerle, Hubin, Pierre, Billuart, Matthieu, Djiena, Achille, Mahieu, Romain, Hammami, Naima, Van Cauteren, Dieter, Wyndham-Thomas, Chloé
Publicado 2023

Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021

por Braeye, Toon, Catteau, Lucy, Brondeel, Ruben, van Loenhout, Joris A.F., Proesmans, Kristiaan, Cornelissen, Laura, Van Oyen, Herman, Stouten, Veerle, Hubin, Pierre, Billuart, Matthieu, Djiena, Achille, Mahieu, Romain, Hammami, Naima, Van Cauteren, Dieter, Wyndham-Thomas, Chloé
Publicado 2022